Sphingolipid perturbations as mechanisms for fumonisin carcinogenesis.
about
Sphingolipid metabolism: roles in signal transduction and disruption by fumonisins.Mycotoxins and human disease: a largely ignored global health issueAn overview of rodent toxicities: liver and kidney effects of fumonisins and Fusarium moniliformeExposure to fumonisins and the occurrence of neural tube defects along the Texas-Mexico border1-Deoxysphingolipids Encountered Exogenously and Made de Novo: Dangerous Mysteries inside an EnigmaFumonisins affect the intestinal microbial homeostasis in broiler chickens, predisposing to necrotic enteritisDistinct generation, pharmacology, and distribution of sphingosine 1-phosphate and dihydrosphingosine 1-phosphate in human neural progenitor cells.Inducible nitric oxide has protective effect on fumonisin B1 hepatotoxicity in mice via modulation of sphingosine kinase.Biodiversity of sphingoid bases ("sphingosines") and related amino alcohols.Mechanisms of sphingosine and sphingosine 1-phosphate generation in human platelets.Inhibition of fumonisin B1 cytotoxicity by nanosilicate platelets during mouse embryo development.Mechanisms of mycotoxin-induced neurotoxicity through oxidative stress-associated pathways.Calcium montmorillonite clay reduces AFB1 and FB1 biomarkers in rats exposed to single and co-exposures of aflatoxin and fumonisinCeramide synthase inhibition by fumonisin B1 causes accumulation of 1-deoxysphinganine: a novel category of bioactive 1-deoxysphingoid bases and 1-deoxydihydroceramides biosynthesized by mammalian cell lines and animalsToxic mechanisms induced by fumonisin b1 mycotoxin on human intestinal cell line.Enzyme characteristics of aminotransferase FumI of Sphingopyxis sp. MTA144 for deamination of hydrolyzed fumonisin B₁.Chronic exposure to deoxynivalenol has no influence on the oral bioavailability of fumonisin B1 in broiler chickensSphingolipid and glycosphingolipid metabolic pathways in the era of sphingolipidomics.Dose-dependent effects on sphingoid bases and cytokines in chickens fed diets prepared with fusarium verticillioides culture material containing fumonisinsFumonisin B1 and risk of hepatocellular carcinoma in two Chinese cohortsMycotoxin fumonisin B1 increases intestinal colonization by pathogenic Escherichia coli in pigsDisruption of sphingolipid metabolism elicits apoptosis-associated reproductive defects in Drosophila.Validation of fumonisin biomarkers in F344 rats.Ceramide as a target in emphysema.Evaluation of sphingolipids in Wistar rats treated to prolonged and single oral doses of fumonisin b₁.Modified hydra bioassay to evaluate the toxicity of multiple mycotoxins and predict the detoxification efficacy of a clay-based sorbentLipid metabolism disorders, lymphocytes cells death, and renal toxicity induced by very low levels of deoxynivalenol and fumonisin b1 alone or in combination following 7 days oral administration to mice.Relationship between mycoparasites lifestyles and biocontrol behaviors against Fusarium spp. and mycotoxins production.Sequential dietary exposure to aflatoxin B1 and fumonisin B1 in F344 rats increases liver preneoplastic changes indicative of a synergistic interactionRole of fumonisin B1 on DNA methylation changes in rat kidney and liver cells.Degradation of Zearalenone by Essential Oils under In vitro Conditions.Expanded genetic map of Gibberella moniliformis (Fusarium verticillioides).Advances in Mycotoxin Research: Public Health Perspectives.Fum3p, a 2-ketoglutarate-dependent dioxygenase required for C-5 hydroxylation of fumonisins in Fusarium verticillioides.Prevalence of aflatoxin and fumonisins (B1 + B2) in maize consumed in rural Malawi.Glycosphingolipid Mediated Caveolin-1 Oligomerization.Biomonitoring of Fusarium spp. mycotoxins: perspectives for an individual exposure assessment tool.Reproductive and sphingolipid metabolic effects of fumonisin B(1) and its alkaline hydrolysis product in LM/Bc mice: hydrolyzed fumonisin B(1) did not cause neural tube defects.Pharmacological antagonism of fumonisin B1 cytotoxicity in porcine renal epithelial cells (LLC-PK1): a model for reducing fumonisin-induced nephrotoxicity in vivo.Lactobacillus plantarum MYS6 Ameliorates Fumonisin B1-Induced Hepatorenal Damage in Broilers.
P2860
Q24537103-30CA0C3C-0AF1-4319-AA5D-F58D6605E32DQ24650056-D384CF95-BC77-4123-9A2D-33A3290EB947Q24815242-547DC80E-0E3B-4624-960B-4E739133943FQ25257385-0F8D4E70-C32D-49A9-8CCE-D539F255B4B0Q26830485-EEFA7E61-27F8-4B67-9F4F-5D17C898B437Q28607348-E00CF636-15F4-4B6E-A480-C996F514913BQ30418836-A4E94381-A5E3-4DDE-A6FB-4153136EF03EQ30443974-98E8AB3A-05A8-49E1-A634-21E199F687ACQ30843994-BF04BF2F-7090-45CD-AEC6-6E851C50C4B9Q34439404-4D5F5057-84B5-4DFE-A2CB-2983F5AB8D48Q34482691-C41F5AD8-9328-4864-8BDE-9795FDFF325CQ34632669-5685373C-9E89-4EAD-9668-105ADF4AF44EQ34652372-49AB8F76-96E6-42CA-AF83-9925358366C0Q34907871-24D8EC20-2713-49CB-80D3-55FA88A1C4CAQ35096940-BE2BBF00-FD7F-4762-B4C9-713E4467E3F1Q35106486-692C0EDE-5AB4-4721-83CF-83CCC15493FCQ35131570-A62F7717-65F1-478A-972E-24E517485CB0Q35324757-CE7D2510-2287-4DA3-B092-95B482936753Q35564054-CE767575-C50C-4B84-83A8-7E105AA88CE9Q35823081-95EBD21D-1B90-4510-996E-B02884FF53CFQ36048742-6DFC8B83-5A14-48E3-9594-52631ED4A83DQ36169377-B3FBDDA9-3D95-40AE-B3EC-D4E2ECF3F676Q36249502-467282C0-AE37-46B3-B234-D3C472DA9F86Q36379401-6C944738-AA42-4CC9-BD37-666A9D935981Q37143177-1B2A87B5-F9BE-4CDC-BA0C-684E0A8DD401Q37360597-FECAC002-ECEF-4B77-B552-4DF47E809622Q37423927-14F20B06-ACAC-4B61-9867-F1EDE5E96429Q38819256-A6771B45-3725-44F0-9F72-71FE1EFFA7E1Q38840465-E84AEE86-8972-419B-B5C0-5C1E0344FC2AQ38889150-729AFAF3-269B-439A-91B5-912C86E19994Q39451833-0FF28659-228D-4B9A-817D-839C9D95DE51Q39639660-955CC141-180D-4344-8F12-FF0AB113FC69Q40324481-2A3988A1-7C7F-4766-9D25-940F635ECAD5Q40743925-7A57C814-D0CF-4B3C-BE85-423996F0057CQ41679646-612D3494-0EAD-4C06-8F74-2DCC8C1A7A2CQ42148671-0252688B-58C9-4CB6-80C2-B81151C47D46Q42749682-3073EB18-0106-4A4C-B610-0C9B81AA06A7Q43270652-4E4301AA-B3D5-4CD1-ACE7-C45E84D3CDDBQ44036367-D81EBD96-0E2D-4942-B2DE-28601247C47BQ46246462-A08826D9-801F-46E7-BA20-7B42AA76C625
P2860
Sphingolipid perturbations as mechanisms for fumonisin carcinogenesis.
description
2001 nî lūn-bûn
@nan
2001 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Sphingolipid perturbations as mechanisms for fumonisin carcinogenesis
@nl
Sphingolipid perturbations as mechanisms for fumonisin carcinogenesis.
@ast
Sphingolipid perturbations as mechanisms for fumonisin carcinogenesis.
@en
type
label
Sphingolipid perturbations as mechanisms for fumonisin carcinogenesis
@nl
Sphingolipid perturbations as mechanisms for fumonisin carcinogenesis.
@ast
Sphingolipid perturbations as mechanisms for fumonisin carcinogenesis.
@en
prefLabel
Sphingolipid perturbations as mechanisms for fumonisin carcinogenesis
@nl
Sphingolipid perturbations as mechanisms for fumonisin carcinogenesis.
@ast
Sphingolipid perturbations as mechanisms for fumonisin carcinogenesis.
@en
P2093
P2860
P921
P3181
P356
P1476
Sphingolipid perturbations as mechanisms for fumonisin carcinogenesis.
@en
P2093
A H Merrill
D B Carlson
D E Williams
E Enongene
F I Meredith
J Spitsbergen
R P Sharma
W P Norred
P2860
P304
P3181
P356
10.1289/EHP.01109S2301
P407
P478
109 Suppl 2
P577
2001-05-01T00:00:00Z